ABSTRACT NUMBER: ESOC2026OT166 SAFETY AND EFFICACY OF EARLY ASPIRIN ADMINISTRATION AFTER INTRAVENOUS THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE (TREND-IVT): A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Wenbo Zhao, Jing Wang, Wei Xu, Lan Liu, Sijie Li, Xunming Ji · 2026

Read ABSTRACT NUMBER: ESOC2026OT166 SAFETY AND EFFICACY OF EARLY ASPIRIN ADMINISTRATION AFTER INTRAVENOUS THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE (TREND-IVT): A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL by Wenbo Zhao, Jing Wang, Wei Xu, Lan Liu, Sijie Li, Xunming Ji (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145119.txt.

Description

Wenbo Zhao and five colleagues present the design of TREND-IVT, a trial testing very early aspirin after clot-busting treatment for stroke. Patients often worsen in the first hours after intravenous thrombolysis, and early decline tracks with poor recovery. Giving a blood thinner sooner might help, but it could also raise bleeding risk.

The multicenter trial in China enrolls stroke patients treated with standard clot-busting drugs who are not headed for a catheter procedure. Half get three hundred milligrams of aspirin within three hours; half get a placebo, with normal antiplatelet care starting at one day for all. The main goal is excellent function at ninety days. Safety checks center on brain bleeding and other bleeding events.

Catalog record

CREATORWenbo Zhao, Jing Wang, Wei Xu, Lan Liu, Sijie Li, Xunming Ji
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13145119

Browse the full library · About the Tower of Babel